Capecitabine monotherapy for recurrent and metastatic nasopharyngeal carcinoma

被引：0
|
作者：
Mehdi, A. [1 ]
Hela, R. [1 ]
机构：
[1] Salah Azaiz Inst, Tunis, Tunisia
来源：
ORAL ONCOLOGY | 2009年
关键词：
D O I：
10.1016/j.oos.2009.06.497
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [41] Detection and staging of recurrent or metastatic nasopharyngeal carcinoma in the era of FDG PET/MR
    Yongfeng Piao
    Caineng Cao
    Yuanfan Xu
    Shuang Huang
    Feng Jiang
    Ting Jin
    Qifeng Jin
    Yonghong Hua
    Qiaoying Hu
    Xiaozhong Chen
    European Archives of Oto-Rhino-Laryngology, 2022, 279 : 353 - 359
  • [42] Detection And Staging Of Recurrent Or Metastatic Nasopharyngeal Carcinoma In The Era Of FDG PET/MR
    Feng, Y.
    Piao, Y.
    Cao, C.
    Xu, Y.
    Hu, Q.
    Chen, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E839 - E839
  • [43] Detection and staging of recurrent or metastatic nasopharyngeal carcinoma in the era of FDG PET/MR
    Piao, Yongfeng
    Cao, Caineng
    Xu, Yuanfan
    Huang, Shuang
    Jiang, Feng
    Jin, Ting
    Jin, Qifeng
    Hua, Yonghong
    Hu, Qiaoying
    Chen, Xiaozhong
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (01) : 353 - 359
  • [44] Palliative Chemotherapy and Targeted Therapy for Recurrent and Metastatic Nasopharyngeal Carcinoma: Reminiscences and the Future
    Lee, V. H. F.
    Kwong, D. L. W.
    HONG KONG JOURNAL OF RADIOLOGY, 2013, 16 (04): : 252 - 260
  • [45] CHEMOTHERAPEUTIC TREATMENT OF RECURRENT AND OR METASTATIC NASOPHARYNGEAL CARCINOMA - A RETROSPECTIVE ANALYSIS OF 40 CASES
    GEBBIA, V
    ZERILLO, G
    RESTIVO, G
    SPECIALE, R
    CUPIDO, G
    LOBUE, P
    INGRIA, F
    GALLINA, S
    SPATAFORA, G
    TESTA, A
    CANNATA, G
    CIMINO, A
    GEBBIA, N
    BRITISH JOURNAL OF CANCER, 1993, 68 (01) : 191 - 194
  • [46] A Phase II Study of Pazopanib in Asian Patients with Recurrent/Metastatic Nasopharyngeal Carcinoma
    Lim, Wan-Teck
    Ng, Quan-Sing
    Ivy, Percy
    Leong, Swan-Swan
    Singh, Onkar
    Chowbay, Balram
    Gao, Fei
    Thng, Choon Hua
    Goh, Boon-Cher
    Tan, Daniel Shao-Weng
    Koh, Tong San
    Toh, Chee-Keong
    Tan, Eng-Huat
    CLINICAL CANCER RESEARCH, 2011, 17 (16) : 5481 - 5489
  • [47] Gemcitabine plus cisplatin for patients with recurrent or metastatic nasopharyngeal carcinoma: a retrospective study
    Kodama, Hiroyuki
    Kadowaki, Shigenori
    Nakata, Akinobu
    Kumanishi, Ryosuke
    Nakazawa, Taiko
    Ogata, Takatsugu
    Matsubara, Yuki
    Honda, Kazunori
    Masuishi, Toshiki
    Narita, Yukiya
    Taniguchi, Hiroya
    Ando, Masashi
    Hanai, Nobuhiro
    Muro, Kei
    ANNALS OF ONCOLOGY, 2022, 33 : S499 - S500
  • [48] A phase II study of axitinib in patients with recurrent or metastatic nasopharyngeal carcinoma (NPC).
    Hui, Edwin Pun
    Ma, Brigette
    Mo, Frankie
    Kam, Michael K. M.
    Chan, Stephen Lam
    Loong, Herbert H. F.
    Ho, Rosalie
    Leung, Sing Fai
    King, Ann Dorothy
    Wang, Ki
    Ahuja, Anil Tejbhan
    Chan, Charles
    Hui, Connie W. C.
    Wong, Chi Hang
    Chan, Anthony T. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [49] Detection and staging of recurrent or metastatic nasopharyngeal carcinoma in the era of FDG PET/MR
    Xu, Yuanfan
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [50] Lactate dehydrogenase kinetics predict chemotherapy response in recurrent metastatic nasopharyngeal carcinoma
    Huang, Luo
    Sim, Adelene Y. L.
    Wu, Yongzhong
    Liang, Zhongguo
    Li, Kaiguo
    Du, Youqin
    Ong, Enya H. W.
    Tan, Hong Qi
    Wee, Joseph T. S.
    Xie, Yue
    Shu, Xiaolei
    Wang, Ying
    Chua, Melvin L. K.
    Zhu, Xiaodong
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
12345